BIOA STOCK NEWS: BioAge Labs Investors are Reminded to Contact BFA Law about the Pending Class Action before the March 10 Deadline
In truth, BioAge was forced to discontinue the STRIDES Phase 2 trial after several subjects exhibited elevated liver enzyme levels, indicating potential organ damage. Consequently, the Company ...
Hosted on MSN1d
William Blair Initiates Coverage of BioAge Labs (BIOA) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Market ...
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn ...
Morningstar2d
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
SAN FRANCISCO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase 2 trial.
Morningstar2d
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
On or about September 2024, BioAge conducted its IPO, selling 12.65 million shares of stock for $18 per share. On December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES ...
Business Wire19d
BIOA INVESTOR ALERT: Kirby McInerney LLP Notifies BioAge Labs, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of the March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf ...
Macau Business1d
BIOA IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses...
Class Action, Consumer Services, GlobeNewswire, Law & Legal Issues | NEW YORK, March 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law ...
Business Wire6d
BIOA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Securities Fraud Class Action Lawsuit
RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc.
Wane1mon
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial – Hagens Berman
SAN FRANCISCO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who ...
Shareholders That Lost Money On Bioage Labs, Inc.(BIOA) Urged To Join Class Action – Contact Levi & Korsinsky To Learn More
WHAT'S NEXT? If you suffered a loss in BioAge during the relevant time frame, you have until March 10, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any ...